United Therapeutics
Price & Volume
Stats
See more52W Range | $272.12-$609.35 |
Market Cap | $23B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $3.1B |
Revenue Growth (YoY) | -1.6% |
Gross Profit (12 Mos) | $2.7B |
Diluted EPS | $27.01 |
News
See moreYahoo Finance • 21 days ago
A Look At United Therapeutics (UTHR) Valuation After Strong Long Term Shareholder Returns
Yahoo Finance • 22 days ago
Healthcare Giants or Medical Innovators? XLV and PINK Are Built for Different Investors.
Yahoo Finance • 23 days ago
Amarin dealt blow as Supreme Court upholds 'skinny labels' for generics
Yahoo Finance • 28 days ago
What to Know About This Fund's $5.4 Million Ultragenyx Purchase as Shares Slip 30% in One Year
About
CEO | Dr. Martine A. Rothblatt J.D., M.B.A., Ph.D. |
CFO | Mr. James C. Edgemond |
Address | 1000 Spring Street, Silver Spring, MD, United States, 20910 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 1,400 |